Literature DB >> 12592306

15. Vasculitis.

Carol A Langford1.   

Abstract

Vasculitis is histologically defined by the presence of blood vessel inflammation. It can be observed in a wide variety of settings, either occurring secondarily to another process or as the pathologic foundation of a primary vasculitic disease. The primary systemic vasculitides comprise a broad group of disease entities that are uniquely identified by the nature of their clinical, histopathologic, or therapeutic characteristics. Individual diseases often predominantly affect blood vessels of a particular size, the pattern of which influences their clinical manifestations and has been used in their classification. The vasculitides span a wide range of disease severity, extending from illnesses that rarely produce death to those almost universally fatal before the introduction of effective therapy. Immunosuppressive and cytotoxic agents are used to treat many vasculitic diseases. Although such approaches can be effective, long-term treatment may be complicated by chronic sequelae from organ damage, disease relapses, and medication side effects. Recent investigations have focused on understanding the pathophysiology of these diseases, which may lead to more efficacious and less toxic therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592306     DOI: 10.1067/mai.2003.80

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer.

Authors:  Humaid O Al-Shamsi; Bryan K Kee; Michael T Tetzlaff; Robert A Wolff
Journal:  J Gastrointest Oncol       Date:  2015-06

2.  Clinical features of polyarteritis nodosa in Korea.

Authors:  Young Deok Bae; Hyo Jin Choi; Jung Chan Lee; Jeong Jin Park; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

3.  Two cases of eosinophilic vasculitis with thrombosis.

Authors:  Ju Kyoung Song; Sung Soo Jung; Seong Wook Kang
Journal:  Rheumatol Int       Date:  2007-08-17       Impact factor: 2.631

Review 4.  Vasculitides and the Complement System: a Comprehensive Review.

Authors:  Maria Sole Chimenti; Eleonora Ballanti; Paola Triggianese; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 10.817

5.  Silica exposure and systemic vasculitis.

Authors:  Karen B Mulloy
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.